BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25906780)

  • 1. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients.
    Campbell DJ; Brown FG; Craig JC; Gallagher MP; Johnson DW; Kirkland GS; Kumar SK; Lim WH; Ranganathan D; Saweirs W; Sud K; Toussaint ND; Walker RG; Williams LA; Yehia M; Mudge DW
    Nephrol Dial Transplant; 2016 Apr; 31(4):619-27. PubMed ID: 25906780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
    Boudville N; Johnson DW; Zhao J; Bieber BA; Pisoni RL; Piraino B; Bernardini J; Nessim SJ; Ito Y; Woodrow G; Brown F; Collins J; Kanjanabuch T; Szeto CC; Perl J
    Nephrol Dial Transplant; 2019 Dec; 34(12):2118-2126. PubMed ID: 30053214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection Prophylaxis in Peritoneal Dialysis Patients: Results from an Australia/New Zealand Survey.
    Campbell DJ; Mudge DW; Gallagher MP; Lim WH; Ranganathan D; Saweirs W; Craig JC
    Perit Dial Int; 2017; 37(2):191-197. PubMed ID: 28096438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
    Perl J; Fuller DS; Bieber BA; Boudville N; Kanjanabuch T; Ito Y; Nessim SJ; Piraino BM; Pisoni RL; Robinson BM; Schaubel DE; Schreiber MJ; Teitelbaum I; Woodrow G; Zhao J; Johnson DW
    Am J Kidney Dis; 2020 Jul; 76(1):42-53. PubMed ID: 31932094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland.
    Lichodziejewska-Niemierko M; Chmielewski M; Wojtaszek E; Suchowierska E; Gołembiewska E; Grajewska M; Matuszkiewicz-Rowińska J; Naumnik B; Sulikowska B; Niemczyk S; Kłak R; Mosakowska M; Jagodziński P; Marcykiewicz B; Kalita K; Krawczyk R; Cieszyński K; Adamski M; Bronk M
    Int Urol Nephrol; 2019 Feb; 51(2):335-341. PubMed ID: 30604230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of Practice in Peritoneal Dialysis in France: Data from the Catheter Section of the RDPLF.
    Lanot A; Bechade C; Verger C; Fabre E; Vernier I; Lobbedez T
    Perit Dial Int; 2018; 38(2):89-97. PubMed ID: 29162681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis practice in Australia and New Zealand: a call to action.
    Jose MD; Johnson DW; Mudge DW; Tranaeus A; Voss D; Walker R; Bannister KM
    Nephrology (Carlton); 2011 Jan; 16(1):19-29. PubMed ID: 21175973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice.
    Bonifati C; Pansini F; Torres DD; Navaneethan SD; Craig JC; Strippoli GF
    Int J Artif Organs; 2006 Jan; 29(1):41-9. PubMed ID: 16485238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prophylactic antibiotics before peritoneal dialysis catheter implantation on the clinical outcomes of peritoneal dialysis patients.
    Liu X; Zuo X; Sun X; Hu Z
    Ren Fail; 2019 Nov; 41(1):16-23. PubMed ID: 30706749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of peritonitis in children: emerging concepts.
    Bakkaloglu SA
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S186-9. PubMed ID: 19270214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential clinical value of catheters impregnated with antimicrobials for the prevention of infections associated with peritoneal dialysis.
    Dukka H; Taal MW; Bayston R
    Expert Rev Med Devices; 2023 Jun; 20(6):459-466. PubMed ID: 37138535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.
    Lopes K; Rocha A; Rodrigues A; Carvalho MJ; Cabrita A
    Int J Artif Organs; 2013 Jul; 36(7):484-8. PubMed ID: 23661559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the management of infective complications of peritoneal dialysis.
    Odudu A; Wilkie M
    Nephron Clin Pract; 2011; 118(3):c301-8. PubMed ID: 21242698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
    Restrepo C; Chacon J; Manjarres G
    Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.
    Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
    Am J Kidney Dis; 2004 Oct; 44(4):591-603. PubMed ID: 15384009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.